{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:01:36Z","timestamp":1792116096406,"version":"4.4.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anaesthesiol Clin Pharmacol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/joacp.joacp_133_18","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T03:06:53Z","timestamp":1575342413000},"page":"450","source":"Crossref","is-referenced-by-count":52,"title":["Meloxicam in the management of post-operative pain: Narrative review"],"prefix":"10.4103","volume":"34","author":[{"given":"Alex","family":"Bekker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Kloepping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shemille","family":"Collingwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0970-9185.249290-1","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1001\/jama.2016.0130","article-title":"Opioids prescribed after low-risk surgical procedures in the United States, 2004-2012","author":"Wunsch","year":"2016","journal-title":"JAMA"},{"key":"key-10.4103\/0970-9185.249290-2","first-page":"248","article-title":"Practice guidelines for acute pain management in the perioperative setting: An updated report by the American Society of Anesthesiologists task force on acute pain management","author":"American","year":"2012","journal-title":"Anesthesiology"},{"key":"key-10.4103\/0970-9185.249290-3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/rheumatology\/35.suppl_1.4","article-title":"Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2","author":"Engelhardt","year":"1996","journal-title":"Br J Rheumatol"},{"key":"key-10.4103\/0970-9185.249290-4","first-page":"1109","article-title":"Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers","author":"Van","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"key-10.4103\/0970-9185.249290-5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/rheumatology\/35.suppl_1.13","article-title":"A review of the clinical pharmacokinetics of meloxicam","author":"T\u00fcrck","year":"1996","journal-title":"Br J Rheumatol"},{"key":"key-10.4103\/0970-9185.249290-6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2014.08.022","article-title":"Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors","author":"Ochi","year":"2014","journal-title":"Int J Pharm"},{"key":"key-10.4103\/0970-9185.249290-7","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.jpain.2016.01.386","article-title":"An evaluation of the efficacy and safety of N1539, a novel intravenous formulation of nanocrystal meloxicam, in subjects with moderate to severe pain following hysterectomy (abstract 409)","author":"Mack","year":"2016","journal-title":"J Pain"},{"key":"key-10.4103\/0970-9185.249290-8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jcph.1058","article-title":"A randomized double-blind controlled trial of intravenous meloxicam in the treatment of pain following dental impaction surgery","author":"Christensen","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"key-10.4103\/0970-9185.249290-9","first-page":"22","article-title":"Clinical pharma-cokinetics of meloxicam","author":"Turck","year":"1995","journal-title":"Eur J Rheumatol Inflamm"},{"key":"key-10.4103\/0970-9185.249290-10","first-page":"39","article-title":"Global analysis of safety of meloxicam, a new enolic acid derived non-steroidal anti-inflammatory agent","author":"Distel","year":"1995","journal-title":"Rheumatol Eur"},{"key":"key-10.4103\/0970-9185.249290-11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0753-3322(89)90140-6","article-title":"Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid","author":"Bannwarth","year":"1989","journal-title":"Biomed Pharmacother"},{"key":"key-10.4103\/0970-9185.249290-12","first-page":"576","article-title":"Pharmacokinetics of meloxicam in animals and the relevance to humans","author":"Busch","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"key-10.4103\/0970-9185.249290-13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00540957","article-title":"The influence of cholestyramine on the elimination of tenoxicam and piroxicam","author":"Guentert","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.4103\/0970-9185.249290-14","first-page":"121","article-title":"Transsynovial kinetics of meloxicam","author":"Degner","year":"1994","journal-title":"Scand J Rheumatol"},{"key":"key-10.4103\/0970-9185.249290-15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/JPR.S149879","article-title":"Evaluation of the safety and efficacy of an intravenous nanocrystal formulation of meloxicam in the management of moderate-to-severe pain after bunionectomy","author":"Gottlieb","year":"2018","journal-title":"J Pain Res"},{"key":"key-10.4103\/0970-9185.249290-16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/rheumatology\/35.suppl_1.17","article-title":"A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis","author":"Reginster","year":"1996","journal-title":"Br J Rheumatol"},{"key":"key-10.4103\/0970-9185.249290-17","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.biopha.2017.08.093","article-title":"Aquaporin-1 expression as an indicator in evaluating the efficacy of meloxicam in the treatment of ankylosing spondylitis: A comparative study","author":"Pan","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"key-10.4103\/0970-9185.249290-18","first-page":"409","article-title":"A method for measurement of analgesic activity on inflamed tissue","author":"Randall","year":"1957","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"key-10.4103\/0970-9185.249290-19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF01757699","article-title":"Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance","author":"Engelhardt","year":"1995","journal-title":"Inflamm Res"},{"key":"key-10.4103\/0970-9185.249290-20","first-page":"436","article-title":"Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: A 12 week multicenter, double blind, dose response study versus placebo and diclofenac","author":"Furst","year":"2002","journal-title":"J Rheumatol"},{"key":"key-10.4103\/0970-9185.249290-21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1517\/17425255.1.4.739","article-title":"Meloxicam in rheumatoid arthritis","author":"Ahmed","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key-10.4103\/0970-9185.249290-22","doi-asserted-by":"crossref","unstructured":"Altman R, Hochberg M, Gibofsky A, Jaros M, Young C. Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: A 12-week, phase 3 study. Curr Med Res Opin 2015;31:2331-43.","DOI":"10.1185\/03007995.2015.1112772"},{"key":"key-10.4103\/0970-9185.249290-23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/rheumatology\/35.suppl_1.39","article-title":"Meloxicam in osteoarthritis: A 6-month, double-blind comparison with diclofenac sodium","author":"Hosie","year":"1996","journal-title":"Br J Rheumatol"},{"key":"key-10.4103\/0970-9185.249290-24","first-page":"530","article-title":"Effect of meloxicam on postoperative pain relief after inguinal hernia repair with local anaesthesia","author":"Kurukahvecioglu","year":"2007","journal-title":"West Indian Med J"},{"key":"key-10.4103\/0970-9185.249290-25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/oxfordjournals.bja.a013395","article-title":"Effect of meloxicam on postoperative pain after abdominal hysterectomy","author":"Thompson","year":"2000","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0970-9185.249290-26","first-page":"289","article-title":"Comparison of pre-emptive effect of meloxicam and celecoxcib on post-operative analgesia: A double-blind, randomized clinical trial","author":"Aghadavoudi","year":"2015","journal-title":"Middle East J Anaesthesiol"},{"key":"key-10.4103\/0970-9185.249290-27","first-page":"CD007552","article-title":"Single dose oral meloxicam for acute postoperative pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0970-9185.249290-28","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.4317\/medoral.20925","article-title":"Single dose of diclofenac or meloxicam for control of pain, facial swelling, and trismus in oral surgery","author":"Orozco-Sol\u00eds","year":"2016","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"key-10.4103\/0970-9185.249290-29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijom.2006.09.006","article-title":"Analgesic and anti-inflammatory dose-response relationship of 7.5 and 15 mg meloxicam after lower third molar removal: A double-blind, randomized, crossover study","author":"Calvo","year":"2007","journal-title":"Int J Oral Maxillofac Surg"},{"key":"key-10.4103\/0970-9185.249290-30","doi-asserted-by":"crossref","unstructured":"Nekoofar MH, Sadeghipanah M, Dehpour AR. Evaluation of meloxicam (A cox-2 inhibitor) for management of postoperative endodontic pain: A double-blind placebo-controlled study. J Endod 2003;29:634-7.","DOI":"10.1097\/00004770-200310000-00005"},{"key":"key-10.4103\/0970-9185.249290-31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40510-015-0104-y","article-title":"Comparison of the effects of preemptive acetaminophen, ibuprofen, and meloxicam on pain after separator placement: A randomized clinical trial","author":"Zarif","year":"2015","journal-title":"Prog Orthod"},{"key":"key-10.4103\/0970-9185.249290-32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/0976-237X.161857","article-title":"An appraisal of innovative meloxicam mucoadhesive films for periodontal postsurgical pain control: A double-blinded, randomized clinical trial of effectiveness","author":"Rajeswari","year":"2015","journal-title":"Contemp Clin Dent","ISSN":"https:\/\/id.crossref.org\/issn\/0976-237X","issn-type":"print"},{"key":"key-10.4103\/0970-9185.249290-33","doi-asserted-by":"crossref","unstructured":"Chen J, Gao Y. Strategies for meloxicam delivery to and across the skin: A review. Drug Deliv 2016;23:3146-56.","DOI":"10.3109\/10717544.2016.1157839"},{"key":"key-10.4103\/0970-9185.249290-34","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/aps.2009.73","article-title":"Pharmacokinetic studies of meloxicam following oral and transdermal administration in beagle dogs","author":"Yuan","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"key-10.4103\/0970-9185.249290-35","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/BF03016587","article-title":"Postoperative analgesia is not different after local vs.systemic administration of meloxicam in patients undergoing inguinal hernia repair","author":"R\u00f8msing","year":"2001","journal-title":"Can J Anaesth"},{"key":"key-10.4103\/0970-9185.249290-36","first-page":"e1846","article-title":"Efficacy and safety of intravenous meloxicam in subjects with moderate-to-severe pain following abdominoplasty","author":"Neil","year":"2018","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"key-10.4103\/0970-9185.249290-37","unstructured":"Berkowitz R, Sharpe K, Mack R, McCallum, S, Gomez A, Freyer A, et al. Safety and Opioid Use Following Major Orthopedic Surgery in a Phase 3, Placebo-Controlled Study of Intravenous Meloxicam. Poster session presented at. Las Vegas, NV: PAINWeek Conference; 2017."},{"key":"key-10.4103\/0970-9185.249290-38","unstructured":"Melson T, Boyer D, Mack R, McCallum S, Gomez A, Freyer A, et al. Safety and Opioid Use in Subjects of Advanced Age with Impaired Renal Function in a Phase 3, Placebo-Controlled Study of Intravenous Meloxicam Following Major Surgery. Poster session presented at. Las Vegas, NV: PAINWeek Conference; 2017."},{"key":"key-10.4103\/0970-9185.249290-39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/00000542-200510000-00023","article-title":"Role for cyclooxygenase 2 in the development and maintenance of neuropathic pain and spinal glial activation","author":"Takeda","year":"2005","journal-title":"Anesthesiology"},{"key":"key-10.4103\/0970-9185.249290-40","first-page":"3567","article-title":"Efficacy of meloxicam in combination with preoperative chemotherapy for breast cancer \u2013 Japan Breast Cancer Research Network (JBCRN) 02-1 trial","author":"Yamamoto","year":"2011","journal-title":"Anticancer Res"},{"key":"key-10.4103\/0970-9185.249290-41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00124743-200212000-00005","article-title":"Prescription and tolerability of meloxicam in day-to-day practice: Postmarketing observational cohort study of 13,307 patients in Germany","author":"Zeidler","year":"2002","journal-title":"J Clin Rheumatol"},{"key":"key-10.4103\/0970-9185.249290-42","doi-asserted-by":"crossref","unstructured":"Hawkey C, Kahan A, Steinbr\u00fcck K, Alegre C, Baumelou E, B\u00e9gaud B, et al. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA study group. Meloxicam large-scale international study safety assessment. Br J Rheumatol 1998;37:937-45.","DOI":"10.1093\/rheumatology\/37.9.937"},{"key":"key-10.4103\/0970-9185.249290-43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2125.1997.tb00135.x","article-title":"Meloxicam pharmacokinetics in renal impairment","author":"Boulton-Jones","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0970-9185.249290-44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10787-014-0225-9","article-title":"The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: A systematic review","author":"Asghar","year":"2015","journal-title":"Inflammopharmacology"}],"container-title":["Journal of Anaesthesiology Clinical Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:41:11Z","timestamp":1786732871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joacp.JOACP_133_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"alternative-id":["249290"],"URL":"https:\/\/doi.org\/10.4103\/joacp.joacp_133_18","relation":{},"ISSN":["0970-9185"],"issn-type":[{"value":"0970-9185","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}